Clinical Trial Update: Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

View source ↗

Summary

This study aims to identify markers of resistance to therapy in HER2-positive breast cancer by analyzing tumor microenvironment spatial interactions; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Giampaolo Bianchini | Conditions: HER2-positive Breast Cancer | Status: RECRUITING